bimi international medical inc - BIMI

BIMI

Close Chg Chg %
0.00 0.00 0.00%

Closed Market

0.00

0.00 (0.00%)

Volume: 50.00K

Last Updated:

Feb 3, 2026, 9:56 AM EDT

Company Overview: bimi international medical inc - BIMI

BIMI Key Data

Open

$0.00

Day Range

0.00 - 0.00

52 Week Range

0.00 - 0.03

Market Cap

$0.00

Shares Outstanding

11.59M

Public Float

11.59M

Beta

-0.69

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$2.09

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

2.32K

 

BIMI Performance

1 Week
 
0.00%
 
1 Month
 
0.00%
 
3 Months
 
0.00%
 
1 Year
 
0.00%
 
5 Years
 
N/A
 

BIMI Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About bimi international medical inc - BIMI

BIMI International Medical, Inc. engages in the provision of healthcare products and services. It operates through the following segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. The Wholesale Pharmaceuticals segment includes supplying prescription and OTC medicines, TCM, healthcare supplies and sundry items to clinics, third party pharmacies, hospitals, and other drug vendors. The Wholesale Medical Devices segment distributes medical devices, including medical consumables to drug stores, private clinics, pharmaceutical dealers and hospitals. The Medical Services segment includes the hospitals acquired in 2021.The Retail Pharmacy segment sells prescription and OTC medicines, traditional Chinese medicines (“TCM”), healthcare supplies, and sundry items to retail customers through its directly-owned pharmacies and authorized retail stores. The company was founded on October 31, 2000 and is headquartered in New York, NY.

BIMI At a Glance

BIMI International Medical, Inc.
725 5th Avenue
New York, New York 10022
Phone 1-212-542-0028 Revenue 11.83M
Industry Medical Distributors Net Income -22,352,754.00
Sector Distribution Services Employees 296
Fiscal Year-end 12 / 2023
View SEC Filings

BIMI Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.277
Price to Book Ratio 1.144
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -0.778
Enterprise Value to Sales 0.64
Total Debt to Enterprise Value 0.721

BIMI Efficiency

Revenue/Employee 39,967.497
Income Per Employee -75,516.061
Receivables Turnover 3.639
Total Asset Turnover 0.32

BIMI Liquidity

Current Ratio 0.916
Quick Ratio 0.355
Cash Ratio 0.092

BIMI Profitability

Gross Margin 16.483
Operating Margin -84.128
Pretax Margin -182.769
Net Margin -188.944
Return on Assets -58.783
Return on Equity -284.803
Return on Total Capital -228.386
Return on Invested Capital -190.129

BIMI Capital Structure

Total Debt to Total Equity 134.777
Total Debt to Total Capital 57.406
Total Debt to Total Assets 15.275
Long-Term Debt to Equity 71.387
Long-Term Debt to Total Capital 30.406
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Bimi International Medical Inc - BIMI

Collapse All in section
All values USD millions. 2019 2020 2021 2022 5-year trend
Sales/Revenue
157.98K 12.84M 27.08M 11.83M
Sales Growth
-97.59% +8,030.82% +110.82% -56.31%
Cost of Goods Sold (COGS) incl D&A
566.10K 10.40M 22.48M 9.88M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
261.98K 56.04K 244.12K 223.56K
Depreciation
4.77K 56.04K 240.66K 220.06K
Amortization of Intangibles
- 257.22K 3.46K 3.50K
COGS Growth
-90.69% +1,737.49% +116.14% -56.05%
Gross Income
(408.13K) 2.44M 4.60M 1.95M
Gross Income Growth
-188.85% +698.55% +88.16% -57.58%
Gross Profit Margin
-258.34% +19.02% +16.97% +16.48%
2019 2020 2021 2022 5-year trend
SG&A Expense
1.30M 6.26M 12.70M 11.90M
Research & Development
- - - -
-
Other SG&A
1.30M 6.26M 12.70M 11.90M
SGA Growth
-91.97% +379.33% +103.09% -6.30%
Other Operating Expense
- - - -
-
Unusual Expense
- - 26.13M 5.39M
-
EBIT after Unusual Expense
(1.71M) (3.81M) (34.24M) (15.34M)
Non Operating Income/Expense
(549.58K) 545.46K (316.19K) (2.85M)
Non-Operating Interest Income
- 304 3.10K 707
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
6.34K 84.91K 351.07K 3.43M
Interest Expense Growth
-98.48% +1,239.32% +313.44% +877.39%
Gross Interest Expense
6.34K 84.91K 351.07K 3.43M
Interest Capitalized
- - - -
-
Pretax Income
(2.27M) (3.35M) (34.90M) (21.62M)
Pretax Income Growth
+86.65% -47.72% -941.32% +38.05%
Pretax Margin
-1,436.28% -26.09% -128.89% -182.77%
Income Tax
- 434.31K 19.37K 6.09K
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(2.27M) (3.79M) (34.92M) (21.63M)
Minority Interest Expense
(13.71K) 119.16K 64.21K 75.20K
Net Income
(2.26M) (3.91M) (34.99M) (21.70M)
Net Income Growth
+86.56% -73.16% -795.88% +37.96%
Net Margin Growth
-1,427.60% -30.40% -129.20% -183.46%
Extraordinaries & Discontinued Operations
- (2.18M) (1.39M) (649.14K)
Discontinued Operations
- (2.18M) (1.39M) (649.14K)
Net Income After Extraordinaries
(4.44M) (5.29M) (34.99M) (22.35M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(4.44M) (5.29M) (34.99M) (22.35M)
EPS (Basic)
-27.1665 -24.7985 -326.1835 -8.3886
EPS (Basic) Growth
+75.80% +8.72% -1,215.34% +97.43%
Basic Shares Outstanding
163.38K 213.46K 107.26K 2.66M
EPS (Diluted)
-27.1665 -24.7985 -326.1835 -8.3886
EPS (Diluted) Growth
+75.80% +8.72% -1,215.34% +97.43%
Diluted Shares Outstanding
163.38K 213.46K 107.26K 2.66M
EBITDA
(1.45M) (3.76M) (7.86M) (9.73M)
EBITDA Growth
+90.17% -158.85% -109.33% -23.74%
EBITDA Margin
-918.55% -29.24% -29.04% -82.24%

Bimi International Medical Inc in the News